277
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Metformin Ameliorates Epithelial–Mesenchymal Transition of Renal Tubular Epithelial Cells in Diabetes by Increasing Vitamin D Receptor Expression

, &
Pages 4001-4010 | Received 20 Sep 2022, Accepted 15 Nov 2022, Published online: 22 Dec 2022

References

  • Tulipano G. Integrated or independent actions of metformin in target tissues underlying its current use and new possible applications in the endocrine and metabolic disorder area. Int J Mol Sci. 2021;22(23):13068. doi:10.3390/ijms222313068
  • Bost F, Rena G, Viollet B. Editorial: metformin: beyond diabetes. Front Endocrinol. 2019;10:851. doi:10.3389/fendo.2019.00851
  • Ravindran S, Kuruvilla V, Wilbur K, Munusamy S. Nephroprotective effects of metformin in diabetic nephropathy. J Cell Physiol. 2017;232(4):731–742. doi:10.1002/jcp.25598
  • Narongkiatikhun P, Chattipakorn SC, Chattipakorn N. Mitochondrial dynamics and diabetic kidney disease: missing pieces for the puzzle of therapeutic approaches. J Cell Mol Med. 2021;26:249–273. doi:10.1111/jcmm.17116
  • Zhang X, Zhou Y, Ma R. Potential effects and application prospect of angiotensin receptor-neprilysin inhibitor in diabetic kidney disease. J Diabetes Complications. 2021;36:108056. doi:10.1016/j.jdiacomp.2021.108056
  • Kong L, Andrikopoulos S, MacIsaac R, et al. The role of the adaptive immune system in diabetic kidney disease (Dkd). J Diabetes Investig. 2021;13:213–226. doi:10.1111/jdi.13725
  • Ahmad AA, Draves SO, Rosca M. Mitochondria in diabetic kidney disease. Cells. 2021;10(11):2945. doi:10.3390/cells10112945
  • Kleinaki Z, Kapnisi S, Theodorelou-Charitou SA, Nikas IP, Paschou SA. Type 2 diabetes mellitus management in patients with chronic kidney disease: an update. Hormones. 2020;19(4):467–476. doi:10.1007/s42000-020-00212-y
  • Zhang L, Long J, Jiang W, et al. Trends in chronic kidney disease in China. N Engl J Med. 2016;375(9):905–906. doi:10.1056/NEJMc1602469
  • Liu H, Yan R, Liang L, et al. The role of Cdx2 in renal tubular lesions during diabetic kidney disease. Aging. 2021;13(5):6782–6803. doi:10.18632/aging.202537
  • Xu Y, Huang J, Xin W, et al. Lipid accumulation is ahead of epithelial-to-mesenchymal transition and therapeutic intervention by acetyl-coa carboxylase 2 silence in diabetic nephropathy. Metabolism. 2014;63(5):716–726. doi:10.1016/j.metabol.2014.02.010
  • Li Y, Xue M, Hu F, et al. Klotho prevents epithelial-mesenchymal transition through Egr-1 downregulation in diabetic kidney disease. BMJ Open Diabetes Res Care. 2021;9(1):e002038. doi:10.1136/bmjdrc-2020-002038
  • Kawanami D, Takashi Y, Tanabe M. Significance of metformin use in diabetic kidney disease. Int J Mol Sci. 2020;21(12):4239. doi:10.3390/ijms21124239
  • Janjusevic M, Gagno G, Fluca AL, et al. The peculiar role of vitamin D in the pathophysiology of cardiovascular and neurodegenerative diseases. Life Sci. 2021;289:120193. doi:10.1016/j.lfs.2021.120193
  • Voutsadakis IA. Vitamin D receptor (Vdr) and Metabolizing Enzymes Cyp27b1 and Cyp24a1 in breast cancer. Mol Biol Rep. 2020;47(12):9821–9830. doi:10.1007/s11033-020-05780-1
  • Battistini C, Ballan R, Herkenhoff ME, Saad SMI, Sun J. Vitamin D modulates intestinal microbiota in inflammatory bowel diseases. Int J Mol Sci. 2020;22(1):362. doi:10.3390/ijms22010362
  • Crescioli C. Vitamin D restores skeletal muscle cell remodeling and myogenic program: potential impact on human health. Int J Mol Sci. 2021;22(4):1760. doi:10.3390/ijms22041760
  • Lei M, Liu Z, Guo J. The emerging role of vitamin D and vitamin D receptor in diabetic nephropathy. Biomed Res Int. 2020;2020:4137268. doi:10.1155/2020/4137268
  • Gembillo G, Cernaro V, Salvo A, et al. Role of vitamin D status in diabetic patients with renal disease. Medicina. 2019;55(6). doi:10.3390/medicina55060273
  • Gembillo G, Siligato R, Amatruda M, Conti G, Santoro D. Vitamin D and Glomerulonephritis. Medicina. 2021;57(2). doi:10.3390/medicina57020186
  • Yang S, Li A, Wang J, et al. Vitamin D receptor: a novel therapeutic target for kidney diseases. Curr Med Chem. 2018;25(27):3256–3271. doi:10.2174/0929867325666180214122352
  • Guan M, Li W, Xu L, et al. Metformin improves epithelial-to-mesenchymal transition induced by tgf-beta1 in renal tubular Epithelial Nrk-52e Cells Via Inhibiting Egr-1. J Diabetes Res. 2018;2018:1031367. doi:10.1155/2018/1031367
  • Song Z, Xiao C, Jia X, et al. Vitamin D/Vdr protects against diabetic kidney disease by restoring podocytes autophagy. Diabetes Metab Syndr Obes. 2021;14:1681–1693. doi:10.2147/DMSO.S303018
  • Yu M, Wu H, Wang J, et al. Vitamin D receptor inhibits emt via regulation of the epithelial mitochondrial function in intestinal fibrosis. J Biol Chem. 2021;296:100531. doi:10.1016/j.jbc.2021.100531
  • Ahmad N, Veerapalli H, Lankala CR, et al. Endothelin receptor antagonists as a potential treatment of diabetic nephropathy: a systematic review. Cureus. 2021;13(11):e19325. doi:10.7759/cureus.19325
  • Zhang X, Shi Z, Liu Q, Quan H, Cheng X. Effects of coenzyme Q10 intervention on diabetic kidney disease: a systematic review and meta-analysis. Medicine. 2019;98(24):e15850. Doi:10.1097/MD.0000000000015850
  • Salvatore T, Pafundi PC, Morgillo F, et al. Metformin: an old drug against old age and associated morbidities. Diabetes Res Clin Pract. 2020;160:108025. doi:10.1016/j.diabres.2020.108025
  • Beladi Mousavi SS, Nasri H, Rafieian-Kopaei M, Tamadon MR.Metformin improves diabetic kidney disease. J Nephropharmacol. 2012;1(1):1–2.
  • Wei L, Li Y, Yu Y, et al. Obesity-related glomerulopathy: from mechanism to therapeutic target. Diabetes Metab Syndr Obes. 2021;14:4371–4380. doi:10.2147/DMSO.S334199
  • Becker AL, Carpenter EL, Slominski AT, Indra AK. The role of the vitamin D receptor in the pathogenesis, prognosis, and treatment of cutaneous melanoma. Front Oncol. 2021;11:743667. doi:10.3389/fonc.2021.743667
  • Campbell MJ, Trump DL. Vitamin D receptor signaling and cancer. Endocrinol Metab Clin North Am. 2017;46(4):1009–1038. doi:10.1016/j.ecl.2017.07.007
  • Libby AE, Jones B, Lopez-Santiago I, Rowland E, Levi M. Nuclear receptors in the kidney during health and disease. Mol Aspects Med. 2021;78:100935. doi:10.1016/j.mam.2020.100935
  • Yang Y, Lei Y, Liang Y, et al. Vitamin D protects glomerular mesangial cells from high glucose-induced injury by repressing jak/stat signaling. Int Urol Nephrol. 2021;53(6):1247–1254. doi:10.1007/s11255-020-02728-z
  • Guo Y, Xie X, Zhao Y, Zhou M, Yang Y, Zhang X. Calcitriol attenuates renal tubular epithelial cells apoptosis via inhibiting P38MAPK signaling in diabetic nephropathy. Acta Diabetol. 2020;57(11):1327–1335. doi:10.1007/s00592-020-01554-0
  • Dong HH, Xiang S, Chen XP, et al. The epithelial-mesenchymal transition promotes transdifferentiation of subcutaneously implanted hepatic oval cells into mesenchymal tumor tissue. Stem Cells Dev. 2009;18(9):1293–1298. doi:10.1089/scd.2008.0321
  • Han J, Pang X, Shi X, Zhang Y, Peng Z, Xing Y. Ginkgo biloba extract Egb761 ameliorates the extracellular matrix accumulation and mesenchymal transformation of renal tubules in diabetic kidney disease by inhibiting endoplasmic reticulum stress. Biomed Res Int. 2021;2021:6657206. doi:10.1155/2021/6657206
  • Xu S, Zhang ZH, Fu L, et al. Calcitriol inhibits migration and invasion of renal cell carcinoma cells by suppressing smad2/3-, Stat3- and beta-catenin-mediated epithelial-mesenchymal transition. Cancer Sci. 2020;111(1):59–71. doi:10.1111/cas.14237